Journal article

The novel adipocytokine visfatin exerts direct cardioprotective effects.

Shiang Y Lim, Sean M Davidson, Ajeev J Paramanathan, Christopher CT Smith, Derek M Yellon, Derek J Hausenloy

J Cell Mol Med | Published : 2008


Visfatin is an adipocytokine capable of mimicking the glucose-lowering effects of insulin and activating the pro-survival kinases phosphatidylinositol-3-OH kinase (PI3K)-protein kinase B (Akt) and mitogen-activated protein kinase kinase 1 and 2 (MEK1/2)-extracellular signal-regulated kinase 1 and 2 (Erk 1/2). Experimental studies have demonstrated that the activation of these kinases confers cardioprotection through the inhibition of the mitochondrial permeability transition pore (mPTP). Whether visfatin is capable of exerting direct cardioprotective effects through these mechanisms is unknown and is the subject of the current study. Anaesthetized C57BL/6 male mice were subjected to in situ ..

View full abstract

University of Melbourne Researchers